Skip to content
healthcare.dev
Get a free key

Alfuzosin hydrochloride

NDC 51655-967, Alfuzosin hydrochloride, tablet, extended release, from Northwind Health Company, LLC.

Product NDC
51655-967
Status
Listed
Labeler
Northwind Health Company, LLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203192
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/51655-967 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALFUZOSIN HYDROCHLORIDE10 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
51655-967-525165509675230 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (51655-967-52)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ffbd22eb-9df5-e0ad-e053-6294a90a7d4e

Use it

Look up 51655-967 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/51655-967 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 51655-967. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.